珈偉新能(300317.SZ)一季度虧損收窄 預虧900萬元-1300萬元
格隆匯4月10日丨珈偉新能(300317.SZ)發佈2020年一季度業績預告,歸屬於上市公司股東的淨虧損900萬元-1300萬元,去年同期則為淨虧損2937.20萬元。
受新型冠狀病毒肺炎疫情影響,公司國內和海外照明業務收入規模同比大幅下降;同時由於產品和業務結構調整,毛利率有所提升,期間費用大幅下降,照明業務營業利潤同比有所提升。
2019年5月完成金湖振合新能源發電有限公司80%股權轉讓,光伏發電收入和利潤同比下降。2019年下半年以來,公司進行戰略調整,進一步精簡和壓縮成本費用,整體固定費用同比大幅降低。報告期內,預計非經常性損益對公司淨利潤的影響金額約為-988萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.